Alps Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 04-10-2024
- Paid Up Capital ₹ 1.09 Cr
as on 04-10-2024
- Company Age 44 Year, 8 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 59.00 Cr
as on 04-10-2024
- Satisfied Charges ₹ 10.00 Cr
as on 04-10-2024
- Revenue -58.06%
(FY 2016)
- Profit 48.62%
(FY 2016)
- Ebitda 41.00%
(FY 2016)
- Net Worth -58.84%
(FY 2016)
- Total Assets -16.42%
(FY 2016)
About Alps Pharmaceuticals
The Corporate was formerly known as Alps Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.09 Cr.
The company currently has active open charges totaling ₹59.00 Cr. The company has closed loans amounting to ₹10.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Parveen Singhal, Ashish Goyal, and Girish Mainali serve as directors at the Company.
- CIN/LLPIN
U24230GJ1980PTC047642
- Company No.
047642
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 1980
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Alps Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parveen Singhal  | Additional Director | 19-Jul-2021 | Current |
| Ashish Goyal | Additional Director | 19-Jul-2021 | Current |
| Girish Mainali | Additional Director | 07-Sep-2024 | Current |
Financial Performance of Alps Pharmaceuticals.
Alps Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 58.06% decrease. The company also saw a substantial improvement in profitability, with a 48.62% increase in profit. The company's net worth observed a substantial decline by a decrease of 58.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alps Pharmaceuticals?
In 2016, Alps Pharmaceuticals had a promoter holding of 7.96% and a public holding of 92.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Green Medi Biotech Private LimitedActive 4 years 6 monthsParveen Singhal and Ashish Goyal are mutual person
- V I P Handlooms Private LimitedActive 26 years 8 months
Parveen Singhal and Ashish Goyal are mutual person
- Northern Erectors Private LimitedActive 38 years 6 months
Parveen Singhal and Ashish Goyal are mutual person
- Ghaziabad Infrastructures Private LimitedActive 10 years 11 months
Parveen Singhal and Ashish Goyal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dena Bank Creation Date: 03 Nov 2009 | ₹29.50 Cr | Open |
Dena Bank Creation Date: 23 Apr 2007 | ₹29.50 Cr | Open |
Global Trade Finance Limited Creation Date: 28 Dec 2006 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Alps Pharmaceuticals?
Unlock and access historical data on people associated with Alps Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alps Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alps Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
